Clinical Trials Browser

OTHER × Prostatic Neoplasms × hydrocortisone hemisuccinate × Clear all

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms